VFEND 200 MG POWDER FOR SOLUTION FOR INFUSION

Ülke: İsrail

Dil: İngilizce

Kaynak: Ministry of Health

Aktif bileşen:

VORICONAZOLE 200 MG/VIAL

Mevcut itibaren:

PFIZER PHARMACEUTICALS ISRAEL LTD

ATC kodu:

J02AC03

Farmasötik formu:

POWDER FOR SOLUTION FOR INFUSION

Uygulama yolu:

I.V

Tarafından üretildi:

PFIZER PGM, FRANCE

Terapötik grubu:

VORICONAZOLE

Terapötik endikasyonlar:

Treatment of : - invasive aspergillosis fluconazole-resistant serious invasive Candida infections (including C. krusei), - serious fungal infections caused by scedosporium spp. and fusarium spp.Vfend should be administered primarily to immunocompromised patients with progressive possibly life-threatening infections. Treatment of candidemia in non neutropenic patients.

Yetkilendirme tarihi:

2012-10-01